GlassScriptPhysician profile
Marc Sandhaus
NPI 1821594490
$2,014.50
in general payments reported to CMS, 2019-2025
9 companies · $881 in 2025
The $881 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.00 · 2022: $27.75 · 2023: $631 · 2024: $460 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,041.89 | 2023-2025 | Watchman Flx, Synergy, Watchman Access System |
| Abiomed | $302.08 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $210.74 | 2023 | Farxiga, Andexxa |
| Edwards Lifesciences Corporation | $156.93 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $123.96 | 2024 | Repatha |
| Biosense Webster, INC. | $71.55 | 2024 | Carto 3 |
| Pfizer INC. | $59.33 | 2021-2023 | |
| Janssen Scientific Affairs, LLC | $27.53 | 2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $20.49 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Sandhaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.